Back to top
more

Insulet (PODD)

(Delayed Data from NSDQ)

$143.05 USD

143.05
1,234,968

-2.37 (-1.63%)

Updated Aug 25, 2026 03:29 PM ET

After-Market: $141.00 -2.05 (-1.43%) 7:42 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.80%
2Buy18.13%
3Hold10.19%
4Sell5.73%
5Strong Sell3.17%
S&P50011.53%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value B Growth C Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 41% (101 out of 246)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Is Phibro Animal Health Stock a Smart Addition to Your Portfolio Now?

by Zacks Equity Research

PAHC rides on strong Animal Health momentum, vaccine growth and emerging market demand, even as macro and competitive risks linger.

Zacks Equity Research

TMO Stock Set to Gain From the Expansion of Gibco Bacto Portfolio

by Zacks Equity Research

Thermo Fisher expands its Gibco Bacto CD portfolio with new formulations aimed at boosting E. coli-based plasmid DNA and protein production efficiency.

Moumi Mondal headshot

4 Medical Device Stocks to Buy for Healthy Returns in 2026

by Moumi Mondal

ISRG, PODD, BSX and IDXX lead medtech innovation with AI, robotics and diagnostics for growth in 2026.

Zacks Equity Research

Should You Continue to Hold EW Stock in Your Portfolio?

by Zacks Equity Research

Edwards Lifesciences leans on growth in Surgical Structural Heart, TAVR and TMTT, though macro pressures and litigation continue to weigh on margins.

Zacks Equity Research

Here is Why Growth Investors Should Buy Insulet (PODD) Now

by Zacks Equity Research

Insulet (PODD) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Zacks Equity Research

PODD Stock Benefits From FDA Approval of Omnipod 5's Enhancements

by Zacks Equity Research

Insulet Stock rises as the FDA clears key Omnipod 5 upgrades that enhance glucose targets and automation for its tubeless diabetes platform.

Zacks Equity Research

Here's Why Insulet (PODD) is a Strong Growth Stock

by Zacks Equity Research

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks Equity Research

Here's Why You Should Add CONMED Stock to Your Portfolio Now

by Zacks Equity Research

CONMED gains momentum from high-margin platforms and supply-chain recovery, even as tariffs and dV5 adoption weigh on near-term margins.

Zacks Equity Research

Looking for a Growth Stock? 3 Reasons Why Insulet (PODD) is a Solid Choice

by Zacks Equity Research

Insulet (PODD) could produce exceptional returns because of its solid growth attributes.

Zacks Equity Research

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

by Zacks Equity Research

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.